The biotech firm Emergent BioSolutions is facing a congressional inquiry Wednesday over alleged deficiencies in their manufacturing of COVID-19 vaccine ingredients.
Emergent BioSolutions faces questions from lawmakers in vaccine probe
© The Crystal Eyes